Please login to the form below

Not currently logged in
Email:
Password:

OPKO appoints vice president of medical affairs

Dr Douglass Laidlaw brings experience from Relypsa and Sanofi

OPKO Health Dr Douglass LaidlawMiami-based OPKO Health has appointed Dr Douglass Laidlaw as vice president of medical affairs.

In his new role, Dr Laidlaw will be particularly responsible for overseeing the anticipated launch of the healthcare company's product Rayaldee.

Dr Laidlaw has over 15 years of experience in leading strategic planning, development and execution of medical education initiatives for numerous pharmaceutical companies, which include Genzyme, Keryx, Neurocine Biosciences and Serono.

He previously served as Relypsa's executive director, medical affairs and Sanofi's national director for medical science liasons, medical affairs.

Philip Frost, chairman and chief executive of OPKO, said: “Doug is a key addition to the management team in OPKO's renal division.

“A well-conceived and executed medical education strategy is critical to Rayaldee's acceptance by US healthcare professionals.”

6th June 2016

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
foxandcat.online

We help communications teams to thrive under pressure. Here at fox&cat, we help all kinds of teams to fight all...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....